Literature DB >> 10560680

Risk of idiopathic venous thromboembolism in users of progestagens alone.

C Vasilakis, H Jick, M del Mar Melero-Montes.   

Abstract

Overall, there was a modest, non-significant, positive association between exposure to progestagens alone and venous thromboembolism (VTE). There was no effect with progestagens alone used for contraception, whereas there was a substantial association with the higher dose progestagens used for other reasons.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10560680     DOI: 10.1016/S0140-6736(99)04394-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  13 in total

1.  Third generation oral contraceptives.

Authors:  D C Skegg
Journal:  BMJ       Date:  2000-07-22

Review 2.  Oral contraceptives and venous thromboembolism: a systematic review and meta-analysis.

Authors:  Lamberto Manzoli; Corrado De Vito; Carolina Marzuillo; Antonio Boccia; Paolo Villari
Journal:  Drug Saf       Date:  2012-03-01       Impact factor: 5.606

Review 3.  Risks of contraception and pregnancy in heart disease.

Authors:  Sara Thorne; Anne MacGregor; Catherine Nelson-Piercy
Journal:  Heart       Date:  2006-10       Impact factor: 5.994

Review 4.  Choosing the best contraceptive method for the adult with congenital heart disease.

Authors:  Candice K Silversides; Mathew Sermer; Samuel C Siu
Journal:  Curr Cardiol Rep       Date:  2009-07       Impact factor: 2.931

5.  35-year-old woman with recurrent palpitations.

Authors:  Kunal C Kadakia; Paul R Daniels
Journal:  Mayo Clin Proc       Date:  2011-08       Impact factor: 7.616

6.  Is progestin an independent risk factor for incident venous thromboembolism? A population-based case-control study.

Authors:  Michel K Barsoum; John A Heit; Aneel A Ashrani; Cynthia L Leibson; Tanya M Petterson; Kent R Bailey
Journal:  Thromb Res       Date:  2010-09-15       Impact factor: 3.944

7.  Contraceptive counseling and use among women with systemic lupus erythematosus: a gap in health care quality?

Authors:  Jinoos Yazdany; Laura Trupin; Rachel Kaiser; Gabriela Schmajuk; Joann Zell Gillis; Eliza Chakravarty; Eleanor Bimla Schwarz
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-11-15       Impact factor: 4.794

8.  Risk of venous thromboembolism among users of third generation oral contraceptives compared with users of oral contraceptives with levonorgestrel before and after 1995: cohort and case-control analysis.

Authors:  H Jick; J A Kaye; C Vasilakis-Scaramozza; S S Jick
Journal:  BMJ       Date:  2000-11-11

Review 9.  Heavy menstrual bleeding: work-up and management.

Authors:  Andra H James
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

Review 10.  Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis.

Authors:  S Mantha; R Karp; V Raghavan; N Terrin; K A Bauer; J I Zwicker
Journal:  BMJ       Date:  2012-08-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.